|
|
The
role of Wobe-Mugos in reducing acute sequele of radiation in head and neck
cancers--a clinical phase-III randomized trial
Kaul
R, Mishra BK, Sutradar P, Choudhary V, Gujral MS
Department
of Radiotherapy, S.G.P.T. Cancer Hospital, Indore, M.P., India
Oral
enzymes act as a potent antiinflammatory, antiedematous agents thereby
decreasing acute toxigenic effect of radiation and increasing compliance,
quality of life of our patients.
Fifty patients were randomized 25 allocated in enzyme and radiotherapy arm, 25
in radiotherapy alone.
Pre RT and post RT biopsies were taken from both arms.
In our study it was found that there was clinical, histopathological as well as
statistical significant difference in both arms.
The enzyme arm patients had mucostis of grade I in 76%, grade II in 12%, grade
III in 8% while as 8% had grade I, 68% grade II, 24% had grade III in RT arm
alone.
In enzyme patients skin reactions of grade I in 72%, 20% had grade II, 8% had
grade III.
In control arm 12% had grade I, 76% had grade II, 8% had grade III skin
reaction.
PMID:
10921218 [PubMed - indexed for MEDLINE]
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10921218&dopt=Abstract
|